pharmaphorum July 7, 2021
A record $14.7 billion in investments was injected into US digital health companies in the first half of this year, overtaking the entire amount raised in 2020 in just six months.
The half saw no fewer than 372 deals with an average size of almost $40 million, with 59% of them worth more than $100 million, according to the analysis from venture fund Rock Health.
Foremost among the transactions was the $540 million seventh-round financing by weight loss and fitness app developer Noom, which it will use to extend its platform into other areas like high blood pressure, diabetes, stress and sleep disorders.
The other two largest deals in the first half were the $500 million raised by Ro –...